APLS 22.17 ▼ -0.23% Live Trading Data - Stocknear

Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
22.17
-0.05 (-0.23%)
At close: Sep 26, 2025, 10:56 AM
-0.23%
Bid 20.11
Market Cap 2.8B
Revenue (ttm) 754.65M
Net Income (ttm) -228.17M
EPS (ttm) -1.83
PE Ratio (ttm) -12.11
Forward PE -25.57
Analyst Hold
Dividends n/a
Ask 23.74
Volume 758,935
Avg. Volume (20D) 2,417,303
Open 20.93
Previous Close 22.22
Day's Range 20.93 - 22.20
52-Week Range 16.10 - 35.72
Beta 0.72
Ex-Dividend Date n/a

About APLS

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APLS
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for APLS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Apellis Pharmaceuticals Inc. is scheduled to release its earnings on Nov 4, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+17.58%
Apellis Pharmaceuticals shares are trading higher ... Unlock content with Pro Subscription
1 month ago
+1.07%
APLS stock has given up its prior gain. Apellis Pharmaceuticals shares were trading higher after the company announced it has won FDA approval for EMPAVELI.